Participating Providers are required to submit requests for services to the Health Plan. CCHP’s Utilization Management (UM) staff reviews authorization requests and the request will either be approved or denied. UM decisions will be communicated in writing to the requesting provider and to the member. The categories that usually require additional UM review include but are not limited to:
Services with the following place-of-service codes
All chemotherapy and high-cost drugs, including but not limited to monoclonal antibodies, immunotherapy, skin substitute, and any medications on the non-preferred drug list of the health plan’s step therapy program
Home health and related services, outpatient occupational therapy, physical therapy, and speech therapy
Chiropractor services
Acupuncture services
Others: radiology (MRIs, scans and nuclear studies), durable medical equipment (DMEs)/prosthetics/orthotics, genetic/molecular testing, hospital-based procedures, implants/stimulators, cosmetic procedures, radiation oncology, transplants, experimental/investigational requests, any codes that are not covered by Medicare
Any codes listed in the prior authorization list
PRIOR AUTHORIZATION LIST
Auth Codes
wdt_ID
wdt_created_by
wdt_created_at
wdt_last_edited_by
wdt_last_edited_at
Code
Code Type
MAM
Full Description
Code Level
Effective From
Effective To
CPT/HCPCS Category Description
CPT Section
1
imLana
30/03/2026 02:54 PM
imLana
30/03/2026 02:54 PM
10004
CPT
FNA BX W/O IMG GDN EA ADDL
Fine needle aspiration biopsy, without imaging guidance; each additional lesion (List separately in addition to code for primary procedure)
NARPOS
19/01/2001
Fine Needle Aspiration
Surgery
2
imLana
30/03/2026 02:54 PM
imLana
30/03/2026 02:54 PM
10005
CPT
FNA BX W/US GDN 1ST LES
Fine needle aspiration biopsy, including ultrasound guidance; first lesion
NARPOS
19/01/2001
Fine Needle Aspiration
Surgery
3
imLana
30/03/2026 02:54 PM
imLana
30/03/2026 02:54 PM
10006
CPT
FNA BX W/US GDN EA ADDL
Fine needle aspiration biopsy, including ultrasound guidance; each additional lesion (List separately in addition to code for primary procedure)
NARPOS
19/01/2001
Fine Needle Aspiration
Surgery
4
imLana
30/03/2026 02:54 PM
imLana
30/03/2026 02:54 PM
10007
CPT
FNA BX W/FLUOR GDN 1ST LES
Fine needle aspiration biopsy, including fluoroscopic guidance; first lesion
NARPOS
19/01/2001
Fine Needle Aspiration
Surgery
5
imLana
30/03/2026 02:54 PM
imLana
30/03/2026 02:54 PM
10008
CPT
FNA BX W/FLUOR GDN EA ADDL
Fine needle aspiration biopsy, including fluoroscopic guidance; each additional lesion (List separately in addition to code for primary procedure)
NARPOS
19/01/2001
Fine Needle Aspiration
Surgery
6
imLana
30/03/2026 02:54 PM
imLana
30/03/2026 02:54 PM
10009
CPT
FNA BX W/CT GDN 1ST LES
Fine needle aspiration biopsy, including CT guidance; first lesion
NARPOS
19/01/2001
Fine Needle Aspiration
Surgery
7
imLana
30/03/2026 02:54 PM
imLana
30/03/2026 02:54 PM
10010
CPT
FNA BX W/CT GDN EA ADDL
Fine needle aspiration biopsy, including CT guidance; each additional lesion (List separately in addition to code for primary procedure)
NARPOS
19/01/2001
Fine Needle Aspiration
Surgery
8
imLana
30/03/2026 02:54 PM
imLana
30/03/2026 02:54 PM
10011
CPT
FNA BX W/MR GDN 1ST LES
Fine needle aspiration biopsy, including MR guidance; first lesion
NARPOS
19/01/2001
Fine Needle Aspiration
Surgery
9
imLana
30/03/2026 02:54 PM
imLana
30/03/2026 02:54 PM
10012
CPT
FNA BX W/MR GDN EA ADDL
Fine needle aspiration biopsy, including MR guidance; each additional lesion (List separately in addition to code for primary procedure)
NARPOS
19/01/2001
Fine Needle Aspiration
Surgery
10
imLana
30/03/2026 02:54 PM
imLana
30/03/2026 02:54 PM
10021
CPT
FINE NEEDLE ASPIRATION BX W/O IMG GDN 1ST LESION
Fine needle aspiration biopsy, without imaging guidance; first lesion
NARPOS
31/12/2000
Fine Needle Aspiration
Surgery
Code
Code Type
MAM
Full Description
Code Level
Effective From
Effective To
CPT/HCPCS Category Description
CPT Section
The list represents medical services and Part B medications (i.e., medications that are delivered in the physician’s office, clinic, outpatient, or home setting) that require authorization prior to being provided or administered. Services must be provided according to Medicare coverage guidelines and must be medically necessary, as established by the Centers for Medicare & Medicaid Services (CMS). Please contact the health plan or consult its Evidence of Coverage for confirmation of coverage.
Services or medications provided without authorization may be subject to retrospective medical necessity review. Submitting all relevant clinical information at the time of the request will facilitate a more expeditious determination. If additional clinical information is required, a health plan representative or designee will request the specific information needed to complete the authorization process. Providers can refer to the Provider Operations Manual for guidelines to submit an authorization request. Providers who participate in an independent practice association (IPA) may be subject to an IPA prior authorization list and should refer to their IPA for guidance.
Note: An approved authorization is not a guarantee of payment. Payment is based on benefits in effect at the time of service, member eligibility, and medical necessity. This list is subject to change at any time without notification.